World's Best Scientists 2026 revealed!
M. John Chapman

M. John Chapman

D-Index & Metrics

Medicine

D-Index
106
Citations
74030
World Ranking
6359
National Ranking
183

M. John Chapman publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where M. John Chapman sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 355 publications — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

M. John Chapman D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where M. John Chapman sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 106 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

M. John Chapman is affiliated with Inserm in France, contributing to the field of medicine with a primary focus on neurology and critical care. Their research spans multiple subfields including neurology, epidemiology, critical care and intensive care medicine, immunology and allergy, and anesthesiology and pain medicine. Chapman's work addresses clinical challenges and outcomes in acute and critical medical conditions.

The scientist's publication record highlights key research topics such as acute ischemic stroke management, traumatic brain injury and neurovascular disturbances, intensive care unit cognitive disorders, anesthesia and sedative agents, food allergy and anaphylaxis research, drug-induced adverse reactions, and the long-term effects of COVID-19.

Chapman has published extensively in several reputable medical journals. Frequent publication venues include the Canadian Medical Association Journal and Critical Care Medicine, each with two publications, as well as Stroke, the Journal of Neurotrauma, and the New England Journal of Medicine.

Selected recent papers include:

  • "Protected Code Stroke," 2020, published in Stroke
  • "Patient Outcomes at Twelve Months after Early Decompressive Craniectomy for Diffuse Traumatic Brain Injury in the Randomized DECRA Clinical Trial," 2020, Journal of Neurotrauma
  • "Liberal or Restrictive Transfusion Strategy in Aneurysmal Subarachnoid Hemorrhage," 2024, New England Journal of Medicine
  • "Effect of inhaled anaesthetics on cognitive and psychiatric outcomes in critically ill adults: a systematic review and meta-analysis," 2023, British Journal of Anaesthesia
  • "Inhaled Volatiles for Status Asthmaticus, Epilepsy, and Difficult Sedation in Adult ICU and PICU: A Systematic Review," 2024, Critical Care Explorations

Frequent collaborators in Chapman's research include Marat Slessarev, Damon C. Scales, Angela Jerath, Brian H. Cuthbertson, and Claudio M. Martin, each contributing to multiple joint publications.

Best Publications

  • 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular riskThe Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

    François Mach;Colin Baigent;Alberico L Catapano;Konstantinos C Koskinas

  • 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

    Alberico L. Catapano;Ian Graham;Guy De Backer;Olov Wiklund

  • Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

    Brian A Ference;Henry N Ginsberg;Ian T. Graham;Kausik K Ray

  • ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)☆☆☆

    Alberico L. Catapano;Zeljko Reiner;Guy De Backer;Ian Graham

  • Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

    Borge G. Nordestgaard;M. John Chapman;Steve E. Humphries;Henry N. Ginsberg

  • Lipoprotein(a) as a cardiovascular risk factor: current status

    Børge G. Nordestgaard;M. John Chapman;Kausik Ray;Jan Borén

  • Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

    M John Chapman;Henry N Ginsberg;Pierre Amarenco;Felicita Andreotti

  • Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

    Erik S. Stroes;Paul D. Thompson;Alberto Corsini;Georgirene D. Vladutiu

  • Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

    Jan Borén;M. John Chapman;M. John Chapman;Ronald M. Krauss;Chris J. Packard

  • 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR).

    Alberico L. Catapano;Ian Graham;Guy De Backer;Olov Wiklund

  • Effect of Two Intensive Statin Regimens on Progression of Coronary Disease

    Stephen J. Nicholls;Christie M. Ballantyne;Philip J. Barter;M. John Chapman

  • Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

    Marina Cuchel;Eric Bruckert;Henry N. Ginsberg;Frederick J. Raal

  • Cholesteryl Ester Transfer Protein: A Novel Target for Raising HDL and Inhibiting Atherosclerosis

    Philip J. Barter;H. Bryan Brewer;M. John Chapman;Charles H. Hennekens

  • Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis

    Anatol Kontush;M. John Chapman

  • ESC/EAS Guidelines for the management of dyslipidaemias

    Alberico L. Catapano;Željko Reiner;Guy De Backer;Ian Graham

  • Familial Hypercholesterolaemia in Children and Adolescents: Gaining Decades of Life by Optimizing Detection and Treatment

    Albert Wiegman;Samuel S. Gidding;Gerald F Watts;M John Chapman

  • Fasting is not routinely required for determination of a lipid profile: Clinical and laboratory implications including flagging at desirable concentration cut-points - A joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine

    Børge G. Nordestgaard;Anne Langsted;Samia Mora;Genovefa Kolovou

  • Dysfunctional HDL and atherosclerotic cardiovascular disease

    Robert S. Rosenson;H. Bryan Brewer;Benjamin J. Ansell;Philip Barter

  • Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes

    Brian A. Ference;Jennifer G. Robinson;Robert D. Brook;Alberico L. Catapano

  • Homozigot ailevi hiperkolesterolemi: klinisyenlerin tanıyı ve klinik yönetimi geliştirmelerine yönelik yeni anlayışlar ve rehberlik. Avrupa Ateroskleroz Derneği’nin Ailevi Hiperkolesterolemi Üzerine Uzlaşı Paneli yazılı görüşü

    Marina Cuchel;Eric Bruckert;Henry N. Ginsberg;Frederick J. Raal

Frequent Co-Authors

Alberico L. Catapano
Alberico L. Catapano University of Milan
Stephen J. Nicholls
Stephen J. Nicholls Monash University
Marja-Riitta Taskinen
Marja-Riitta Taskinen University of Helsinki
Henry N. Ginsberg
Henry N. Ginsberg Columbia University
Lale Tokgozoglu
Lale Tokgozoglu Hacettepe University
Jan Borén
Jan Borén University of Gothenburg
Børge G. Nordestgaard
Børge G. Nordestgaard University of Copenhagen
Christie M. Ballantyne
Christie M. Ballantyne Baylor College of Medicine
Raimund Erbel
Raimund Erbel University of Duisburg-Essen
Peter Libby
Peter Libby Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine often begins with exploring accessible online degree options in healthcare. For those considering nursing, there are many cheap online nursing programs that provide flexible and budget-friendly pathways into the profession. These programs are ideal for students balancing work or family commitments.

Experienced nurses looking to advance into leadership or specialized roles can explore the cheapest dnp programs, which offer advanced clinical training at a more affordable cost. Additionally, registered nurses aiming to obtain their bachelor's degree can find what is the cheapest rn to bsn program online to help expand career opportunities and meet evolving healthcare standards.

For individuals with a non-nursing background seeking a fast path into advanced practice, there are direct entry msn programs for non-nurses online. These programs offer a streamlined route into nursing at the master’s level, catering to career changers and those eager to make an impact in healthcare.

Best Scientists Citing M. John Chapman

Trending Scientists

Recently Published Articles